Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children.

Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy

Di Cicco Maria
Primo
;
Di Gangi Alessandro;Masini Beatrice;Peroni Diego;
2021-01-01

Abstract

Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children.
2021
DI CICCO, Maria; Del Tufo, Ester; Parolo, Eva; Menconi, Mariacristina; Bernasconi, Sayla; Romei, Chiara; DI GANGI, Alessandro; Masini, Beatrice; Peron...espandi
File in questo prodotto:
File Dimensione Formato  
2021-Dicicco-ruxolitinib.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 366.52 kB
Formato Adobe PDF
366.52 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1109402
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact